Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site
- PMID: 1310781
- PMCID: PMC240938
- DOI: 10.1128/JVI.66.3.1781-1785.1992
Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site
Abstract
The avian sarcoma and leukosis viruses (ASLV) encode a protease (PR) at the C terminus of gag which in vivo catalyzes the processing of both gag and gag-pol precursors. The studies reported here were undertaken to determine whether PR is able to cleave these polyproteins while it is still part of the gag precursor or whether the release of its N terminus to form free PR is necessary for full proteolytic activity. To address this question, we created a mutation that disrupts the PR cleavage site between the NC and PR coding regions of the gag gene. This mutation was introduced into a eukaryotic vector that expresses only the gag precursor and into an otherwise infectious clone of ASLV that carries the neo gene as a selectable marker. These constructs were expressed in monkey COS cells or in quail QT35 cells, respectively. Processing was impaired in both systems. Mutant particles were formed, but they contained no mature processed gag proteins. We observed only the uncleaved gag precursor polypeptide Pr76 in one case or Pr76 and a cleaved product of about 60 kDa in the other. Processing of the mutant gag precursor could be complemented in trans by from a wild-type construct, suggesting that the mutation did not induce gross structural alterations in its precursor. Our results suggest that the PR first must be released from its precursor before it can attack other sites in the gag and gag-pol polyproteins and that cleavage at the NC-PR boundary is a prerequisite for the initiation of the PR-directed processing.
Similar articles
-
trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.J Virol. 1991 Nov;65(11):6218-31. doi: 10.1128/JVI.65.11.6218-6231.1991. J Virol. 1991. PMID: 1717719 Free PMC article.
-
Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.J Virol. 1997 Mar;71(3):2083-91. doi: 10.1128/JVI.71.3.2083-2091.1997. J Virol. 1997. PMID: 9032340 Free PMC article.
-
Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.J Virol. 1997 Jan;71(1):444-50. doi: 10.1128/JVI.71.1.444-450.1997. J Virol. 1997. PMID: 8985369 Free PMC article.
-
Proteolytic processing of foamy virus Gag and Pol proteins.Curr Top Microbiol Immunol. 2003;277:63-88. doi: 10.1007/978-3-642-55701-9_3. Curr Top Microbiol Immunol. 2003. PMID: 12908768 Review.
-
Synthesis, Assembly, and Processing of Viral Proteins.In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997. In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997. PMID: 21433349 Free Books & Documents. Review.
Cited by
-
Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism.J Virol. 2004 Aug;78(16):8477-85. doi: 10.1128/JVI.78.16.8477-8485.2004. J Virol. 2004. PMID: 15280456 Free PMC article.
-
Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.J Virol. 1994 Jan;68(1):240-50. doi: 10.1128/JVI.68.1.240-250.1994. J Virol. 1994. PMID: 8254734 Free PMC article.
-
A p6Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1.J Virol. 1996 Oct;70(10):7228-32. doi: 10.1128/JVI.70.10.7228-7232.1996. J Virol. 1996. PMID: 8794372 Free PMC article.
-
Reversal by dithiothreitol treatment of the block in murine leukemia virus maturation induced by disulfide cross-linking.J Virol. 2002 Oct;76(19):10050-5. doi: 10.1128/jvi.76.19.10050-10055.2002. J Virol. 2002. PMID: 12208984 Free PMC article.
-
Ty1 proteolytic cleavage sites are required for transposition: all sites are not created equal.J Virol. 2001 Jan;75(2):638-44. doi: 10.1128/JVI.75.2.638-644.2001. J Virol. 2001. PMID: 11134277 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials